
Maharishi V. Khirodhar
Examiner (ID: 10559, Phone: (571)270-7909 , Office: P/2463 )
| Most Active Art Unit | 2463 |
| Art Unit(s) | 2463, 2416 |
| Total Applications | 881 |
| Issued Applications | 739 |
| Pending Applications | 63 |
| Abandoned Applications | 97 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6246041
[patent_doc_number] => 20100136109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'SUSTAINED RELEASE'
[patent_app_type] => utility
[patent_app_number] => 12/597153
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7860
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136109.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597153
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597153 | SUSTAINED RELEASE | Apr 21, 2008 | Abandoned |
Array
(
[id] => 8527421
[patent_doc_number] => 08303990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Otologic nanotechnology'
[patent_app_type] => utility
[patent_app_number] => 12/148738
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3578
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12148738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148738 | Otologic nanotechnology | Apr 21, 2008 | Issued |
Array
(
[id] => 8527373
[patent_doc_number] => 08303941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Chelated mineral water'
[patent_app_type] => utility
[patent_app_number] => 12/596603
[patent_app_country] => US
[patent_app_date] => 2008-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1994
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12596603
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596603 | Chelated mineral water | Apr 18, 2008 | Issued |
Array
(
[id] => 5507932
[patent_doc_number] => 20090081139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Water-based delivery systems'
[patent_app_type] => utility
[patent_app_number] => 12/082406
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6569
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081139.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082406
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082406 | Water-based delivery systems | Apr 8, 2008 | Abandoned |
Array
(
[id] => 5322864
[patent_doc_number] => 20090060854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Dermatological Compound'
[patent_app_type] => utility
[patent_app_number] => 12/098241
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2750
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12098241
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/098241 | Dermatological Compound | Apr 3, 2008 | Abandoned |
Array
(
[id] => 10887785
[patent_doc_number] => 08911777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Pharmaceutical composition of tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 12/594553
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 13015
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594553 | Pharmaceutical composition of tacrolimus | Apr 3, 2008 | Issued |
Array
(
[id] => 4764699
[patent_doc_number] => 20080175910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'PHARMACEUTICAL DOSAGE FORMS FOR CONTROLLED RELEASE PRODUCING AT LEAST A TIMED PULSE'
[patent_app_type] => utility
[patent_app_number] => 12/053833
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4106
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175910.pdf
[firstpage_image] =>[orig_patent_app_number] => 12053833
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/053833 | PHARMACEUTICAL DOSAGE FORMS FOR CONTROLLED RELEASE PRODUCING AT LEAST A TIMED PULSE | Mar 23, 2008 | Abandoned |
Array
(
[id] => 5447105
[patent_doc_number] => 20090048331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'METHODS AND FORMULATIONS FOR THE DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/051782
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4450
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048331.pdf
[firstpage_image] =>[orig_patent_app_number] => 12051782
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/051782 | METHODS AND FORMULATIONS FOR THE DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS | Mar 18, 2008 | Abandoned |
Array
(
[id] => 4820631
[patent_doc_number] => 20080226689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles'
[patent_app_type] => utility
[patent_app_number] => 12/075435
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7909
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075435 | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | Mar 10, 2008 | Issued |
Array
(
[id] => 6421659
[patent_doc_number] => 20100151035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF POORLY SOLUBLE DRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/529504
[patent_app_country] => US
[patent_app_date] => 2008-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4314
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151035.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529504 | PHARMACEUTICAL COMPOSITIONS OF POORLY SOLUBLE DRUGS | Mar 9, 2008 | Abandoned |
Array
(
[id] => 6429968
[patent_doc_number] => 20100143274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS'
[patent_app_type] => utility
[patent_app_number] => 12/529573
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8446
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143274.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529573 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | Feb 26, 2008 | Abandoned |
Array
(
[id] => 6246072
[patent_doc_number] => 20100136119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'CONTROLLED-RELEASE PREPARATION CONTAINING CILOSTAZOL AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/527024
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4604
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136119.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527024
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527024 | CONTROLLED-RELEASE PREPARATION CONTAINING CILOSTAZOL AND PROCESS FOR THE PREPARATION THEREOF | Feb 14, 2008 | Abandoned |
Array
(
[id] => 6352783
[patent_doc_number] => 20100086493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'PURE CHLORINE DIOXIDE SOLUTION, AND GEL-LIKE COMPOSITION AND FOAMING COMPOSITION EACH COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/531244
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5734
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086493.pdf
[firstpage_image] =>[orig_patent_app_number] => 12531244
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531244 | PURE CHLORINE DIOXIDE SOLUTION, AND GEL-LIKE COMPOSITION AND FOAMING COMPOSITION EACH COMPRISING THE SAME | Feb 14, 2008 | Abandoned |
Array
(
[id] => 12543234
[patent_doc_number] => 10010612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Sustained delivery formulations of risperidone compounds
[patent_app_type] => utility
[patent_app_number] => 12/602058
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 28
[patent_no_of_words] => 42914
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602058
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602058 | Sustained delivery formulations of risperidone compounds | Feb 12, 2008 | Issued |
Array
(
[id] => 4827244
[patent_doc_number] => 20080125543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Cationic Block Copolymers'
[patent_app_type] => utility
[patent_app_number] => 12/021338
[patent_app_country] => US
[patent_app_date] => 2008-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7814
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125543.pdf
[firstpage_image] =>[orig_patent_app_number] => 12021338
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/021338 | Cationic Block Copolymers | Jan 28, 2008 | Abandoned |
Array
(
[id] => 4825101
[patent_doc_number] => 20080124392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Extended release formulation'
[patent_app_type] => utility
[patent_app_number] => 12/011367
[patent_app_country] => US
[patent_app_date] => 2008-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5011
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124392.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011367 | Extended release formulation | Jan 24, 2008 | Abandoned |
Array
(
[id] => 6591687
[patent_doc_number] => 20100062216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'PACKAGING SHEET FOR ABSORBING BIOFLUID AND PRODUCT MANUFACTURED THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/524658
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5943
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062216.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524658 | PACKAGING SHEET FOR ABSORBING BIOFLUID AND PRODUCT MANUFACTURED THEREFROM | Jan 23, 2008 | Abandoned |
Array
(
[id] => 6468086
[patent_doc_number] => 20100040668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/522800
[patent_app_country] => US
[patent_app_date] => 2008-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7411
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040668.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522800
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522800 | Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof | Jan 10, 2008 | Abandoned |
Array
(
[id] => 4903611
[patent_doc_number] => 20080113024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Methods and compositions for treating platelet-related disorders'
[patent_app_type] => utility
[patent_app_number] => 12/008204
[patent_app_country] => US
[patent_app_date] => 2008-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17041
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113024.pdf
[firstpage_image] =>[orig_patent_app_number] => 12008204
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/008204 | Methods and compositions for treating platelet-related disorders | Jan 7, 2008 | Abandoned |
Array
(
[id] => 6339578
[patent_doc_number] => 20100247473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'POLYMERIC THICKENER COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/734530
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4742
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12734530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/734530 | Polymeric thickener composition | Dec 20, 2007 | Issued |